Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Bivalent or Tetravalent HPV Vaccine in HIV-Infected Adults
2011-001871-37Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- May 2011
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in human papillomavirus infection comparing Quadrivalent HPV vaccine (Gardasil) with Bivalent HPV vaccine (Cervarix) (2 arms). Primary endpoints: Serum neutralization titer of anti-HPV-16 antibodies, Serum neutralization titer of anti-HPV-18 antibodies and 1 more. Started May 2011; status: completed.
02
Drugs
qHPV vaccinehuman papillomavirus type 16 L1 capsid protein antigen
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on 2011-001871-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001871-37.